TABLE 5.
Characteristic | Lab 1 | Lab 2 | Lab 3 | Lab 4 | Lab 7 | Lab 8 | Lab 9 | Lab 10 | Lab 11 |
---|---|---|---|---|---|---|---|---|---|
In-house method | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Concentration of sample | No | No | No | No | No | No | No | No | Centrifugation |
Extraction method | Boil | Silicaa | GuSCNb | MagnaPurec | Qiagend | Boil | Qiagen | Amplicore | Qiagen |
Eq. sample used for PCRf | 1 | 5 | 4 | 20 | 8 or 20 | 10 | 12.5 | 5 | 12.5 |
Amplification method | Single PCR | Real time | Nested PCR | Real time | Real time | Nested PCR | Real time | Real time | Real time |
Target gene | IS481-IS1001 | ?g | IS481-IS1001 | IS481-IS1001 | IS481-IS1001 | ? | IS481 + ptxA Prh | IS481 | Pertactin |
Detection method | Gel | Taqmani | Gel | Taqman | Taqman | Gel | FRET probe | Taqman | Taqman |
Analytical sensitivity (per ml) | 1,000 CFU | Unknown | Unknown | Unknown | 125 CFU | 10 cells | 200 CFU | Unknown | Unknown |
No. of separate areas | 3 | 3 | 4 | 1 | 3 | 4 | 3 | 3 | 2 |
Carryover prevention | No | dUTPj | No | dUTP | No | No | dUTP | dUTP | dUTP |
Silica extraction method.
GuSCN, guanidine thiocyanate lysis and isopropanol precipitation.
MagnaPure (Roche Diagnostics).
QIAamp DNA mini kit (Qiagen).
Amplicor respiratory specimen preparation kit.
Equivalent (Eq.) sample used for PCR (in microliters), calculated as the starting volume used for concentration and extraction × fraction of extracted volume added to the amplification mixture.
?, participant did not answer.
ptxA Pr, pertussis toxin promoter.
Taqman double dye probe.
Addition of dUTP and uracil glycosylase.